Ara
Toplam kayıt 25, listelenen: 11-20
Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis
(Pagepress Publ, 2021)
The incidence of psoriasis in patients with rheumatoid arthritis (RA) is higher than in the general population. In addition, psoriasis may negatively affect the severity of rheumatological diseases in patients with ...
Treatment Satisfaction, Expectations, Patient Preferences, and Characteristics in Patients with Rheumatoid Arthritis (Ra): Turkish Cohort Results of the Sense Study
(Bmj Publishing Group, 2021)
[No Abstract Available]
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
(Springer Heidelberg, 2021)
We wanted to see how close we could get to our goal of treating rheumatoid arthritis (RA) without the use of glucocorticoids (GCs) in the disease-modifying antirheumatic drugs (DMARDs) era using real-life data. Established ...
Enthesitis may be one of the signs of severe disease in familial Mediterranean fever
(Springer London Ltd, 2021)
Objective Familial Mediterranean fever (FMF) is an auto-inflammatory disease that is also characterized with some of the common musculoskeletal features of spondyloarthritis (SpA). Enthesitis is the hallmark of SpA. Recently, ...
Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database
(Clinical & Exper Rheumatology, 2021)
Objective To explore the impact of early versus late-onset psoriasis (PsO) on the disease characteristics of psoriatic arthritis (PsA) in a large-multicentre cohort. Methods The data from a multicentre psoriatic arthritis ...
Do Peripheral and Extra Musculoskeletal Manifestations Have An Impact on Biologic Dmard Prescribing Patterns in Axial Spondyloarthritis: the Results of Treasure Experience
(Bmj Publishing Group, 2021)
[No Abstract Available]
Familial Mediterranean Fever Patients may have Unmet Needs for the Treatments of Exertional Leg Pain and Enthesitis
(Ediciones Doyma, S.L., 2021)
Introduction: Exertional leg pain (ELP) and enthesitis are musculoskeletal findings in familial Mediterranean fever (FMF). They are not accepted as principal treatment targets. In this study, we assessed the effectiveness ...
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
(Springer Heidelberg, 2022)
This study aimed to compare Tuberculin Skin Test (TST) and QuantiFERON (R)-TB Gold In-Tube (QFT-GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients scheduled for biological and targeted synthetic ...
Familial mediterranean fever patients may have unmet needs for the treatments of exertional leg pain and enthesitis
(Elsevier Espana Slu, 2022)
Introduction: Exertional leg pain (ELP) and enthesitis are musculoskeletal findings in familial Mediterranean fever (FMF). They are not accepted as principal treatment targets. In this study, we assessed the effectiveness ...
THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA
(Bmj Publishing Group, 2022)
[Abstract Not Available]